Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1969 1
1974 1
1984 1
1995 1
1997 1
1999 1
2001 1
2002 1
2004 2
2006 2
2007 1
2009 1
2010 1
2012 4
2013 1
2015 1
2016 2
2017 3
2018 1
2019 3
2020 1
2022 6
2023 2
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Esophageal Diffuse Large B-Cell Lymphoma"
Page 1
The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S, Yim S, Park H. Chang S, et al. Exp Mol Med. 2019 Jun 20;51(6):1-17. doi: 10.1038/s12276-019-0230-6. Exp Mol Med. 2019. PMID: 31221981 Free PMC article. Review.
Table 1 Cancer driver genes involved in epigenetics Pathways involved in epigenetics Driver genes Tumor suppressor/oncogene prediction (by 20/20+(a)) Approved name Activity Cancer type(b) Other driver genes in this pathways Histone modification KDM6A tsg Lysine demethylase …
Table 1 Cancer driver genes involved in epigenetics Pathways involved in epigenetics Driver genes Tumor suppressor/oncogene prediction …
LncRNA SBF2-AS1: A Budding Star in Various Cancers.
Tan F, Chen J, Wang B, Du Z, Mou J, Wu Y, Liu Y, Zhao F, Yuan C. Tan F, et al. Curr Pharm Des. 2022;28(18):1513-1522. doi: 10.2174/1381612828666220418131506. Curr Pharm Des. 2022. PMID: 35440300 Review.
Accumulating evidence has demonstrated that lncRNA SBF2-AS1 participates in the progression of the various tumor, including pathogenesis, diagnosis, treatment, and prognosis of acute myeloid leukemia (AML), breast cancer (BC), cervical cancer (CC), clear cell renal cell ca …
Accumulating evidence has demonstrated that lncRNA SBF2-AS1 participates in the progression of the various tumor, including pathogenesis, di …
Identification and Validation of a Prognostic Prediction Model in Diffuse Large B-Cell Lymphoma.
Yan J, Yuan W, Zhang J, Li L, Zhang L, Zhang X, Zhang M. Yan J, et al. Front Endocrinol (Lausanne). 2022 Apr 14;13:846357. doi: 10.3389/fendo.2022.846357. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35498426 Free PMC article.
BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group with varied pathophysiological, genetic, and clinical features, accounting for approximately one-third of all lymphoma cases worldwide. ...Of note, we found that t …
BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group with varied pathophysiological …
High-intensity chemotherapy improved the prognosis of patients with high-grade B-cell lymphoma.
Chen Y, Cai Q, Chang Y, Zhang M, Li Z. Chen Y, et al. Front Immunol. 2022 Dec 23;13:1047115. doi: 10.3389/fimmu.2022.1047115. eCollection 2022. Front Immunol. 2022. PMID: 36618391 Free PMC article.
OBJECTIVE: High-grade B-cell lymphoma (HGBL) is highly aggressive and has a poor prognosis. ...The clinical features, treatment and prognosis of patients with two types of high-grade B-cell lymphoma were compared and analyze …
OBJECTIVE: High-grade B-cell lymphoma (HGBL) is highly aggressive and has a poor prognosis. ...The clinical feat …
Cancer genetics and genomics of human FOX family genes.
Katoh M, Igarashi M, Fukuda H, Nakagama H, Katoh M. Katoh M, et al. Cancer Lett. 2013 Jan 28;328(2):198-206. doi: 10.1016/j.canlet.2012.09.017. Epub 2012 Sep 27. Cancer Lett. 2013. PMID: 23022474 Review.
FOXM1 is overexpressed owing to gene amplification in basal-type breast cancer and diffuse large B-cell lymphoma (DLBCL), and it is transcriptionally upregulated owing to Hedgehog-GLI, hypoxia-HIF1alpha or YAP-TEAD signaling activation. ...FOXP1 …
FOXM1 is overexpressed owing to gene amplification in basal-type breast cancer and diffuse large B-cell lymph …
Mutant p53 Gain of Function and Chemoresistance: The Role of Mutant p53 in Response to Clinical Chemotherapy.
He C, Li L, Guan X, Xiong L, Miao X. He C, et al. Chemotherapy. 2017;62(1):43-53. doi: 10.1159/000446361. Epub 2016 Jun 21. Chemotherapy. 2017. PMID: 27322648 Review.
Major mechanisms of mutp53-induced chemoresistance include enhanced drug efflux and metabolism, promoting survival, inhibiting apoptosis, upregulating DNA repair, suppressing autophagy, elevating microenvironmental resistance and inducing a stem-like phenotype. Clinically, mutp53 …
Major mechanisms of mutp53-induced chemoresistance include enhanced drug efflux and metabolism, promoting survival, inhibiting apoptosis, up …
APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S, Li Y, Xu J, Shen L. Zhao S, et al. Neurol Res. 2024 Mar;46(3):227-242. doi: 10.1080/01616412.2023.2287340. Epub 2024 Jan 22. Neurol Res. 2024. PMID: 38007705
RESULTS: A3C expression was significantly higher in LGGs than in normal tissues but lower than in glioblastoma (GBM), indicating its role as an independent prognosis predictor for LGGs. Twenty-eight A3C-related genes were found with WGCNA for unsupervised clustering …
RESULTS: A3C expression was significantly higher in LGGs than in normal tissues but lower than in glioblastoma (GBM), indicating its role as …
Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis.
Gao ZW, Yang L, Liu C, Wang X, Guo WT, Zhang HZ, Dong K. Gao ZW, et al. Front Immunol. 2022 May 18;13:903461. doi: 10.3389/fimmu.2022.903461. eCollection 2022. Front Immunol. 2022. PMID: 35663977 Free PMC article.
RESULTS: ADA1 was significantly increased in several tumor tissues, including cholangiocarcinoma (CHOL), lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), head and neck squamous cell carcinoma (HNSC), kidney renal clear cell carcinoma (KIR …
RESULTS: ADA1 was significantly increased in several tumor tissues, including cholangiocarcinoma (CHOL), lymphoid neoplasm diffuse …
Advancing Pan-cancer Gene Expression Survial Analysis by Inclusion of Non-coding RNA.
Ye B, Shi J, Kang H, Oyebamiji O, Hill D, Yu H, Ness S, Ye F, Ping J, He J, Edwards J, Zhao YY, Guo Y. Ye B, et al. RNA Biol. 2020 Nov;17(11):1666-1673. doi: 10.1080/15476286.2019.1679585. Epub 2019 Oct 18. RNA Biol. 2020. PMID: 31607216 Free PMC article.
Our analyses showed that non-coding RNAs perform as well as messenger RNAs in predicting survival of cancer patients. These results reinforce the potential prognostic value of non-coding RNAs. ...Abbreviation: ACC: Adrenocortical Carcinoma (n = 92); BLCA: Bladder Ur …
Our analyses showed that non-coding RNAs perform as well as messenger RNAs in predicting survival of cancer patients. These results r …
Primary composite lymphoma of the larynx, composed of diffuse large B-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified, presenting as left subglottic tracheal fistula, esophageal diverticulum, and neck abscess.
Cui W, Fan F, Zhang D, Garnett D, Tilzer L. Cui W, et al. Ann Clin Lab Sci. 2012 Winter;42(1):73-80. Ann Clin Lab Sci. 2012. PMID: 22371913
Primary laryngeal lymphoma occurs very rarely, accounting for far less than 1% of primary malignant laryngeal neoplasms. To the best of our knowledge, primary laryngeal composite lymphoma has not been reported in the literature. Herein, we report the first case of p …
Primary laryngeal lymphoma occurs very rarely, accounting for far less than 1% of primary malignant laryngeal neoplasms. To the best …
38 results